{"name": "SymBio Pharmaceuticals",
 "permalink": "symbio-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/symbio-pharmaceuticals",
 "homepage_url": "http://www.symbiopharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "(03) 5472-1125",
 "description": "",
 "created_at": "Sat Feb 26 03:42:03 UTC 2011",
 "updated_at": "Sat Feb 26 03:42:02 UTC 2011",
 "overview": "\u003Cp\u003ESymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin\u0026#8217;s lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       72],
      "assets/images/resized/0012/4055/124055v1-max-150x150.jpg"],
     [[182,
       88],
      "assets/images/resized/0012/4055/124055v1-max-250x250.jpg"],
     [[182,
       88],
      "assets/images/resized/0012/4055/124055v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Fuminori",
      "last_name": "Yoshida",
      "permalink": "fuminori-yoshida",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Hiroki",
      "last_name": "Maekawa",
      "permalink": "hiroki-maekawa",
      "image": null}},
   {"is_past": false,
    "title": "Lead Board Member",
    "person":
     {"first_name": "Lowell",
      "last_name": "Sears",
      "permalink": "lowell-sears",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$24M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "http://www.symbiopharma.com/en/news/110225e.pdf",
    "source_description": "SymBio Pharmaceuticals Successfully Completes JPY2.0 Billion (USD24 Million) Series E Private Placement",
    "raised_amount": 24000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 25,
    "investments":
     [{"company":
        {"name": "Cephalon",
         "permalink": "cephalon",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0007/7997/77997v1-max-150x150.jpg"],
             [[233,
               73],
              "assets/images/resized/0007/7997/77997v1-max-250x250.jpg"],
             [[233,
               73],
              "assets/images/resized/0007/7997/77997v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "San-Ei Bldg.,8F 5-23-7 Shimbashi",
    "address2": "Minato-ku",
    "zip_code": "105-0004",
    "city": "Tokyo ",
    "state_code": null,
    "country_code": "JPN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}